Oct 16 (Reuters) - Ipsen SA IPN.PA :
* HEALTH CANADA APPROVES XERMELO™ (TELOTRISTAT ETHYL) FOR TREATMENT OF ADULT PATIENTS SUFFERING FROM REFRACTORY CARCINOID SYNDROME DIARRHEA(1)
Oct 16 (Reuters) - Ipsen SA IPN.PA :
* HEALTH CANADA APPROVES XERMELO™ (TELOTRISTAT ETHYL) FOR TREATMENT OF ADULT PATIENTS SUFFERING FROM REFRACTORY CARCINOID SYNDROME DIARRHEA(1)